Is the optimal dose of preoperative statin associated with decreased end organ injury and better clinical outcome post cardiopulmonary bypass?
Phase of Trial: Phase IV
Latest Information Update: 04 May 2013
At a glance
- Drugs Atorvastatin (Primary) ; HMG-CoA reductase inhibitors
- Indications Coronary disorders; End-organ damage; Inflammation
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 21 Jan 2013 New trial record